XSHG
600628
Market cap613mUSD
Oct 09, Last price
6.46CNY
1D
1.73%
1Q
10.43%
Jan 2017
-54.28%
Name
Shanghai New World Co.
Chart & performance
P/E
62.69
P/S
3.79
EPS
0.10
Div yield, %
0.63%
Shrs. gr., 5y
0.75%
Rev. gr., 5y
1.03%
Revenues
1.10b
-1.69%
Net income
67m
-4.82%
CFO
169m
-47.22%
Dividend
Aug 14, 20260.04 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Shanghai New World Co., Ltd. owns and operates department stores in China. The company produce and distributes Chinese herbal medicines; and sells Chinese patent medicines, western medicines, ginseng and antler tonics, and nutritional health products. It also involved in hotel, investment consulting and management, property and project management, advertising, dining, entertainment, e-commerce, clothing, trading, tourism, leisure, and retail pharmaceutical businesses, as well as provides Chinese herbal medicine consultation and prescription services. The company was founded in 1988 and is headquartered in Shanghai, China.
Key people
Jia Ping Xu
Vice Chairman of the Board, General Manager
Wenyi Zheng
Chief Financial Officer, Deputy General Manager · since 2018
Fengming Chen
Deputy General Manager · since 2017
Zhen Gu
Deputy General Manager · since 2011
Yu Guo
Deputy General Manager · since 2015
Shengjun Wu
Deputy General Manager · since 2018
Jianying Ye
Deputy General Manager · since 2003
Bingfang Ma
Deputy General Manager, Secretary of the Board · since 2008
Qiaoming Bai
Director · since 2011
Qi Wang
Director
Ruohai Xu
Chairman of the Board · since 2011
Fanghua Wang
Independent Director · since 2008
Independent Director · since 2008
Independent Director · since 2008
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||